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Abstract
The success of forensic investigations involving fatalities very often depends on the establishment of the correct
timeline of events. Currently used methods for estimating the postmortem interval (PMI) are mostly dependent on
the professional and tacit experience of the investigator, and often with poor reliability in the absence of robust
biological markers. The aim of this study was to investigate the potential of metabolomic approaches to high-
light molecular markers for PMI. Rat and human muscle tissues, collected at various times postmortem, were
analyzed using an untargeted metabolomics approach. Levels of certain metabolites (skatole, xanthine,
n-acetylneuraminate, 1-methylnicotinamide, choline phosphate, and uracil) as well as most proteinogenic amino
acids increased steadily postmortem. Threonine, tyrosine, and lysine show the most predictable evolution over the
postmortem period, and may thus have potential for possible PMI markers in the future. This study demonstrates
how a biomarker discovery approach can be extended to forensic investigations using untargeted metabolomics.
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Introduction
Estimation of postmortem interval (PMI) plays acentral role in the course of many forensic investiga-
tions. Unfortunately, it is also one of the most challenging
tasks in crime investigation. Knowing when death occurred
may help clarify the circumstances of a death and to assess
the alibis of potential suspects in a suspicious death (Kaliszan
et al., 2009). However, current methods to determine PMI,
including temperature measurement (algor mortis), assess-
ment of rigor mortis and livor mortis (lividity), and mor-
phological changes in the body (Swift, 2006), are often
inaccurate and depend greatly on the tacit professional
experience of the forensic investigator (Aydin et al., 2010).
Various other methods have been proposed over the
years (Kang et al., 2003; Lange et al., 1994; Rognum et al.,
1991; Sampaio-Silva et al., 2013; Shirley and Wood, 2013;
Usumoto et al., 2010), but with limited success due to the
complexity of the decomposition process. Margins of error
in field forensic assessments of PMI can exceed 40%
(Kaliszan et al., 2009), even when conventional methods are
combined. There is a clear need for a reliable, quantitative,
and objective method for PMI estimation.
Global or ‘‘omics’’ systems science approaches, such as
proteomics and metabolomics, have led to the identification
of biomarkers that have diagnostic or prognostic utility to
forecast health and disease states (Blasco et al., 2014; Fedele
et al., 2013; Gonza´lez-Domı´nguez et al., 2014; LeWitt et al.,
2013; Manna et al., 2015; Pena et al., 2015). Untargeted
metabolomics can report on the relative abundances of a
broad range of small molecules (such as amino acids, oligo-
peptides, sugars, bile acids, and fatty acids) in any biological
system of interest (Clarke and Haselden, 2008).
Various metabolites have previously been investigated for
use in PMI estimation. Harada et al. (1984) investigated
the changes in levels of specific metabolites (lactate, alanine,
pyruvate, and glucose) in animal organs and tissues (liver,
kidney, spleen, brain, heart, and dorsal muscle) and found a
correlation between PMI and levels of lactate and pyruvate in
the heart and muscle tissue. Sparks et al. (1986) presented a
linear relationship between 3-methoxytyramine (3-MT) and
PMI in the dorsal putamen. The authors also concluded that
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this relationship varies with the cause of death. In cases where
the cause of death was attributed to a heart disease, 3-MT was
negatively correlated with PMI, while being positively cor-
related in cases with other causes of death.
Four other studies reported metabolites that evolve over
time in postmortem sheep brain (Ith et al., 2002; Ith et al., 2011;
Musshoff et al., 2011; Scheurer et al., 2005). Free trimethy-
lammonium (fTMA), propionate, and butyrate were found in
all three investigations, among other compounds emerging
postmortem. Ith et al. (2002) also included human brain in the
study, and found similarities between the decomposition of
human and sheep brain. Banaschak et al. (2005) investigated
the postmortem changes in pig brain, and also identified fTMA
in their study, as well as creatinine, lactate, acetate, alanine,
and succinate, which all emerged in postmortem tissue.
More recently, Mao et al. (2013) showed a correlation
between PMI and the breakdown products of adenosine tri-
phosphate in rat brain, kidney, and spleen. Donaldson et al.
(2013) observed that the concentrations of hypoxanthine,
ammonia, formic acid, and nicotinamide adenine dinucleo-
tide (NADH) increase in rat, pig, and human blood post-
mortem. Kang et al. were one of the first groups to utilize a
global mass spectrometry-based metabolomics approach
(as opposed to metabolite assays) in PMI estimation. Meta-
bolites extracted from rat livers over the first 48 h postmortem
were analyzed by ultra performance liquid chromatography/
quadrupole-time of flight mass spectrometry (UPLC/Q-TOF
MS). Statistical analysis of the data yielded 15 potential
biomarker candidates, including various polysaccharides,
steroids, nucleosides, and amino acids (Kang et al., 2012).
We used an untargeted comparative metabolomics approach
to identify putative molecular markers that predictably evolve
over time after death. The instrumentation most commonly
employed for metabolomics includes liquid chromatography-
mass spectrometry (LC-MS) and gas chromatography-mass
spectrometry. These techniques allow identification and rela-
tive quantitation of low molecular weight molecules (up to
*1000 Da). Here, we report the development of a mass
spectrometry-based metabolomics approach to identify PMI
biomarkers in a rodent model and the application of this ap-
proach to human cadavers with known PMI.
Materials and Methods
Research ethics
This study involved both human and animal postmortem
samples. The six cadavers used in this research project were
donated to the Forensic Anthropology Center at Texas State
(FACTS) University, San Marcos, Texas. The donations
were made voluntarily in life by the individuals themselves or
by next of kin after death, in accordance with the Texas
Anatomical Gift Program. All legal documents permitting the
release of the remains to FACTS and informed consent were
obtained for each subject.
Work with human remains was performed with the ap-
proval of Texas State University. FACTS receives whole-
body donations for scientific research under the Texas revised
Uniform Anatomical Gift Act (Texas Health and Safety Title
8, Chapter 691 and 692). Body donations are exclusively
acquired by Texas State University through the expressed and
documented willing of the donors and/or their legal next of
kin. Body donations are made directly to FACTS, and donors
and/or their legal next of kin are aware that donations are
used for taphonomic studies. Upon receipt of a body dona-
tion, a number is assigned to the donation, and the name
and personal information are not accessible to the researcher.
The body donation program complies with all legal and
ethical standards associated with the use of human remains
for scientific research.
Human tissue samples were collected according to guide-
lines approved by FACTS, which complied with all legal and
ethical standards associated with the use of human remains
for scientific research, as detailed above. The present work
was conducted within the oversight of all host organizations.
The local research ethics committee chair at the University
of Glasgow where molecular analyses were performed has
advised the authors and waived the ethics approval in
Glasgow, in light of ethics approval at the FACTS, the U.S.
collaborating center.
All human subjects admitted to the FACTS during a 2-
week period were included in the study, provided their lower
limbs were intact and suitable for sampling. Basic anony-
mous information on the individuals, including the cause and
time of death, was recorded, as shown in Table 1. All ap-
plicable international, national, and/or institutional guide-
lines for the care and use of animals were followed. All
animal postmortem samples were obtained after animals
were euthanized strictly adhering to Schedule 1 of the UK
Animals (Scientific Procedures) Act 1986.
Sample collection
Rat tissue. Initially, rat cadavers were used as an animal
model to test the methodology. Eight male adult Wistar
rats (283–309 g, average weight 296.5 g) were euthanized
through carbon dioxide asphyxiation, per Schedule 1 of the UK
Animals (Scientific Procedures) Act 1986, as noted above.
Table 1. Description of the Human Cadavers Included in the Study
Subject ID Gender Age Cause of death Sampling period (days) PMI (days)
1* Male 60 Hemorrhagic stroke 4 7, 8, 9, 10
2* Male 62 Pulmonary embolism 4 11, 12, 13, 14
3* Female 69 Suicide—GSW (chest) 5 11, 12, 13, 14, 15
4 Male 59 Acute respiratory distress syndrome 3 3, 4, 5
5* Male 69 Metastatic nonsmall cell lung cancer 5 12, 13, 14, 15, 16
6 Male 60 Cardiovascular disease 2 18, 19
Cadavers stored in refrigerated conditions are marked with an asterisk.
PMI at the time of sampling.
GSW, gun-shot wound; PMI, postmortem interval.
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Two of the rats were immediately dissected, and the biceps
femoris muscle tissue was collected from both left and right
sides of the body, giving four replicate tissue samples from
two animals. The six remaining rat cadavers were stored in a
covered plastic box at 20C (–2C), and were dissected as
described above at 24 h intervals postmortem over three
consecutive days (two rats per day, four samples per day).
The collected tissue was immediately weighed, cut into 0.5 g
portions, placed in separate cryogenic vials (Nunc Cryo-
Tubes, 1.8 mL; Sigma-Aldrich, Dorset, UK), and snap frozen
in liquid nitrogen. Samples were then stored at -80C until
analysis.
Human tissue. Samples were collected from human
cadavers at a similar time each day of sampling. The days on
which samples were collected postmortem from each cadaver
are listed in Table 1. Four of the six cadavers (subjects 1, 2, 3,
and 5) were refrigerated (in body bags) throughout the period
of sampling at 7.2C (45F). This temperature is routinely
used to refrigerate cadavers at FACTS. Shortly before sam-
pling, the bodies were removed from the fridge, right leg of
the cadaver was lifted up, and a single incision was made at
the back of the leg, along the biceps femoris muscle line. The
underlying muscle tissue (biceps femoris) was exposed, and a
piece of the muscle was cut out using a scalpel. The collected
tissue was then weighed into six 1 g (approximately) portions
and put into separate screw top vials (microtubes 2 mL; PP—
Sarstedt, Leicester, UK).
The incision was covered with surgical tape, and the ca-
davers were returned to the refrigerator immediately after
sampling. Subsequent sampling was performed from the
same incision to avoid further invasive procedures. The
bodies were returned to the refrigerator immediately after
sampling. The collected samples were kept on dry ice for
*1.5 h until they were stored at -80C.
The other two individuals (subjects 4 and 6) were placed
outdoors, and facing down for easy access to the sampling
site, and preserved in a secure exposed environment. During
the 5-day period when these two cadavers were sampled,
the average temperature was 23.3/17.8C (day/night) and the
average relative humidity was 61.7/85.9% (day/night). An
incision was made to expose the muscle, and a piece of biceps
femoris was collected. The tissue was immediately wrapped
in a piece of aluminum foil and placed in a sealed plastic bag
to be transported to the laboratory. The incision site was
covered up with tape to prevent the development of insect
activity in the wound.
At the laboratory, the tissue was cut up and weighed into
six portions of*1 g. They were then placed in vials and kept
on dry ice for*1.5 h, before being stored in a -80C freezer
until shipment to the United Kingdom where they were also
stored at -80C. The muscle tissue was processed and ana-
lyzed at the University of Glasgow.
Sample preparation
While this study did not conduct formal statistical hypothesis
testing due to limited sample size, it offers important and new
insights on PMI research. Here, we describe, additionally, how
data were organized and reported. Four separate pieces of rat
tissue (two rats, right and left leg) and three separate pieces of
human tissue were used for each time point.
Tissue samples (0.5 g) were homogenized in 5 mL of
chloroform/methanol/water solution 20:60:20 (v/v/v)
(t’Kindt et al., 2010) using a handheld homogenizer (Cole-
Palmer) and shaken on ice for 1 h using a rocking table
(150 rpm; Lab-Shaker LS-X, Kuhner, Switzerland). After
extraction, samples were centrifuged at 14,000 g for 30 min.
One milliliter of the supernatant was transferred to an Ep-
pendorf tube and centrifuged again at 16,000 g for 10 min.
Samples were then transferred to fresh Eppendorf tubes and
stored at -80C until analysis.
Sample analysis
Ten microliters of each sample was used for analysis us-
ing hydrophilic interaction LC-MS (UltiMate 3000 RSLC;
Thermo Scientific, San Jose, CA) with a 150· 4.6 mm ZIC-
pHILIC analytical column (Merck SeQuant, Umea, Sweden)
running at 300lL/min, coupled to an Exactive (Thermo
Scientific) for MS detection. Buffers consisted of A: 20 mM
ammonium carbonate (Sigma Aldrich) in H2O (LC-MS
Grade; Rathburn, Walkerburn) and B: acetonitrile (LC-MS
Grade; Rathburn). The gradient ran from 80% B to 20% B in
15 min, followed by a wash at 5% B for 3 min, and equilibration
at initial conditions for 5 min. Column conditions were main-
tained in a column oven at a fixed temperature of 25C.
The Exactive (Thermo Scientific, Waltham, MA) was used
to detect ions using a HESI-II interface with a source tem-
perature of 150C and a capillary temperature of 270C.
Sheath gas flow rate was 40, auxiliary gas flow rate was 5, and
sweep gas flow rate was 1. Each sample was injected using
alternating detection in positive ion and negative ion using
polarity switching mode; the spray voltage was 4.5 and
3.5 kV, respectively. Full scan MS detection was acquired for
the range 70 to 1400 m/z at 50,000 (at 400 m/z) resolution for
each polarity.
For better detection and identification of different groups
of compounds, the samples were also analyzed using a ZIC-
HILIC analytical column (150 · 4.6 mm; Merck SeQuant)
coupled to the same LC-MS system. Method parameters
were the same as above with the exception of the buffers
used—A: 0.1% formic acid and B: 0.08% formic acid, both
in acetonitrile.
Raw mass spectrometry data were processed using the
University of Glasgow Polyomics pipeline, consisting of
XCMS (Smith et al., 2006) (for peak picking), MzMatch
(Scheltema et al., 2011) (for filtering and grouping), and
IDEOM (Creek et al., 2012) (for further filtering, post-
processing, and identification). Core metabolite identifi-
cations were validated against a panel of unambiguous
standards by mass and retention times. Additional putative
identifications were assigned by accurate mass along with a
retention time prediction algorithm (Creek et al., 2011).
Mean and standard deviation of the mean were generated for
all groups of picked peaks.
PMI calculations
PMI is most often reported using the amount of time,
which has passed since the moment of death. However, the
temperature at which the cadaver decomposes has a signifi-
cant effect on the rate of decomposition. Therefore, the PMI
calculation is sometimes corrected to include the temperature
measurement. For example, Vass et al. (2002) reported PMI
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values in cumulative degree hours (CDH). To allow for
comparison of results presented in this article with the
existing literature, the PMI of subjects included in this study
is also presented in CDH (Table 2).
Calculations were based on the assumption that the human
cadavers were stored at 4C at the medical examiner’s office
in between the discovery and receipt at the FACTS. The
calculations of CDH for the storage period at 4C were
summed with the storage at FACTS (at 7.2C) to reflect the
change in temperature. For cadavers stored outside, actual
environmental temperature measurements were used for
CDH calculations.
Results
Untargeted metabolomics approach was used to identify
possible biomarkers of PMI. Rat and human skeletal muscle
samples were collected at varying times postmortem and
analyzed as a time course. This approach allowed the de-
tection and putative identification of 1753 (pHILIC) and 1080
(HILIC) metabolites in rat tissue and 1393 (pHILIC) and
1464 (HILIC) for the human subjects. These numbers reflect
the peaks that could be matched within 3 ppm of calculated
metabolite masses, and are therefore, class II identifications
according to the Metabolite Standards Initiative (Sumner
et al., 2014).
The majority of the detected molecules were peptides. The
other groups of detected metabolites involved diverse path-
ways, including amino acid, carbohydrate, nucleotide, and
lipid metabolism, as well as molecules with no confirmed
metabolic role. Figure 1 shows the number of common me-
tabolites between the rat and the human tissue for each
chromatographic method.
Rat tissue
Amino acids. Nineteen of 20 of the proteinogenic amino
acids were identified (with the exception of isoleucine).
Sixteen of them showed steadily increasing patterns over
PMI. The remaining three (glycine, alanine, and glutamine)
showed less change over the investigated time period.
Figure 2 shows the changes observed in 11 of those amino
acids, which were identified with high confidence.
Among all of the detected amino acids, cysteine showed
the highest rate of increase, *22-fold by the third-day
postmortem. However, it is not shown in Figure 2 as a po-
tential biomarker candidate as the calculated standard devi-
ation at one of the time points was very high (20.03– 10.21).
Leucine and aspartate increased 13-fold in that time, fol-
lowed by valine with a 10-fold increase. Most of the other
amino acids increased between four- and eightfold with
proline increasing at the slowest rate of twofold change over
the same time period and arginine and lysine threefold.
In addition, since two rat cadavers were sampled at each
time point, their metabolite levels were compared with each
other. The relative levels of the metabolites differed; how-
ever, the rates of increase of four amino acids (histidine,
lysine, proline, and asparagine) showed similarities between
rats sampled at the same time point.
Decomposition products. Biogenic amines, such as ca-
daverine, putrescine, indole, and skatole, are well-known
decomposition products (Vass, 2001). They are formed by
bacterial breakdown of amino acids after death but are also
present in living tissue (Wishart et al., 2013). Cadaverine is a
product of lysine metabolism, putrescine of arginine and
proline metabolism, and both indole and skatole are produced
Table 2. Sampling Times for Human Subjects
Included in this Study as Postmortem Interval
(in Days) and Cumulative Degree Hour
Unit
Time
point 1
Time
point 2
Time
point 3
Time
point 4
Time
point 5
Subject 1 PMI 7 8 9 10 X
CDH 81.6 96.0 110.4 124.8 X
Subject 2 PMI 11 12 13 14 X
CDH 88.0 102.4 116.8 131.2 X
Subject 3 PMI 11 12 13 14 15
CDH 107.2 121.6 136.0 150.4 164.8
Subject 4 PMI 3 4 5 X X
CDH 137.4 178.9 222.4 X X
Subject 5 PMI 12 13 14 15 16
CDH 108.8 123.2 137.6 152.0 166.4
Subject 6 PMI 18 19 X X X
CDH 144.0 186.0 X X X
CDH was calculated according to Vass et al., 2002.
X indicates that no data were collected for this time point.
CDH, cumulative degree hours.
FIG. 1. Venn diagrams showing the number of common
and uncommon metabolites detected in rat and human tis-
sues. Graph (a) shows metabolites separated using pHILIC
and (b) shows metabolites separated using HILIC.
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from tryptophan. All four of these compounds were detected.
Putrescine, skatole, and indole increased in abundance over
the 3 day time course by *4-, 7-, and 8-fold, respectively.
Unexpectedly, cadaverine decreased by *3-fold over the
3 day time course (Fig. 3).
Other metabolites. Five other compounds of interest
were selected as potential markers of the PMI based on their
steadily increasing change over time as well as on the con-
fidence in the compound identification: xanthine (from purine
metabolism), n-acetylneuraminate (a derivative of neur-
aminic acid), uracil (from pyrimidine metabolism), choline
phosphate (from glycerophospholipid metabolism), and 1-
methylnicotinamide (a metabolite of nicotinamide) (Wishart
et al., 2013). Xanthine displayed the most significant increase
of *58-fold over 3 days postmortem. N-acetylneuraminate
and uracil showed a slower, but still significant, rate of in-
crease, *24- and 15-fold, respectively (Fig. 4a). Choline
phosphate also increased consistently over the investigated
period but by a smaller factor of twofold (Fig. 4b).
Human tissue
Human tissue was prepared and analyzed in the same way
as rat tissue, with the exception of data processing. In the
case of rat tissue, rats dissected at the same time point were
treated as biological replicates, and data for all cadavers were
analyzed collectively. Whereas due to the high variability
between individual human cadavers (due to cause of death,
age, sex, diet, environmental exposure since death, etc.), the
data collected for each cadaver were processed as an indi-
vidual time course to demonstrate changes in the metabolome
in comparison with baseline.
Amino acids. As was the case for rat tissue, generally
increasing patterns for most of the amino acids were observed
for all of the tested human cadavers, with the exception of
subject 1. Figure 5 shows an example of how the levels of one
of the amino acids of interest (leucine) changed over time in
each of the subjects. Similar trends were observed for nearly
all of the proteinogenic amino acids with the exception of
FIG. 2. Fold change in signal for 11 amino acids in rat tissue with increasing PMI. Signal at each time point was
normalized to time 0. Error bars indicate standard deviation between four samples. Two rats were analyzed per time point,
from each hind limb, giving four replicate samples at each time point. PMI, postmortem interval.
FIG. 3. Patterns of change in identified decomposition products with increasing PMI in rat tissue shown as fold change
with respect to time of death, with error bars indicating the standard deviation (n = 4).
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glutamine and alanine. Not every metabolite behaved the
same in each test subject, but leucine, tryptophan, tyrosine,
threonine, lysine, phenylalanine, and aspartate showed stea-
dy increases in all. The quantitative changes in amino acid
levels were more variable between human individuals than
the rat subjects (Fig. 2).
Although similar trends were observed in all subjects, it
was difficult to draw conclusions based on this particular set
of subjects due to differences in storage conditions of the
cadavers as well as their different PMIs. The instrumental
response of amino acids for subjects 2, 3, and 5 (who were of
similar age and PMI) was normalized to PMI 12 in each
subject (the first common time point for all of the three
subjects). These are shown in Figure 6. Four amino acids
(glutamate, histidine, lysine, and serine) show similar rates of
increase for the two male subjects, while lysine and tyrosine
show an overlap for subjects 3 and 5—female and male,
respectively. Cysteine and serine show an overlap for all
three subjects. This finding is in agreement with data col-
lected from rat cadavers, especially for histidine and lysine,
which showed similar rates of increase in individual rat
subjects.
FIG. 4. Metabolites that increased in rat tissue with increasing PMI shown as fold change with respect to time of death,
with error bars indicating the standard deviation (n = 4). The metabolites above, with the exception of 1-methylnico-
tinamide, were identified by matching to a reference standard. Panels a and b present different scales.
FIG. 5. Changes in leucine, as an exemplar marker, over PMI for several human cadavers. Leucine levels are shown as
fold change with respect to time of death, normalized to the level of leucine in the earliest sample available for each subject:
(a) subjects 2, 3, and 5 (similar PMI); (b) subject 1; (c) subject 4; and (d) subject 6. A steady increase in leucine level can be
seen for all of the subjects, with exception of subject 1. The analysis included three technical replicates of each sample.
6 PESKO ET AL.
Tyrosine, threonine, and lysine, among the amino acids,
showed the most consistent increases over time between
different individuals. In addition, as mentioned above, they
showed similar rates of change for subjects of similar age and
PMI, suggesting that they are promising candidates for PMI
biomarkers.
Other metabolites. The known decomposition products
cadaverine, putrescine, and indole, which showed promising
changes in rat tissue, did not show similar changes in human
tissue. In some cases, no changes were detected. However,
another decomposition product (skatole) was consistently
identified in five of the six tested subjects and showed in-
creasing patterns for four of the five subjects (with the ex-
ception of subject 1).
As in the case of rat tissue, five metabolites (xanthine, cho-
line phosphate, uracil, n-acetylneuraminate, and 1-methyl-
nicotinamide) showed steadily increasing patterns in each of
the subjects. Generally increasing patterns were observed for
all of these metabolites in each of the cadavers, with the
FIG. 6. Selected amino acids showing a similar trend of increase over time for different human subjects at the same PMI:
(a) glutamate, (b) histidine (two male subjects), (c) lysine (male and a female), and (d) serine (all three subjects). Signal was
normalized to PMI 12 (first common time point for all subjects). Error bars indicate standard deviation between three
technical replicates for each sample.
FIG. 7. Graphs showing examples of PMI changes in human cadavers of levels of metabolites of interest (n-acetyl-
neuraminate, 1-methylnicotinamide, choline phosphate, xanthine, uracil, and skatole), shown as fold change with respect to
time of death. Data shown for two of the human cadavers: (a) subject 2 and (b) subject 5, normalized to signal in the earliest
sample available for each subject. Error bars indicate standard deviation between three technical replicates for each sample.
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exception of subject 4. However, in this case tissue collection
was only possible at three time points, and the cadaver was
stored outdoors. N-acetylneuraminate showed the highest
rate of increase over time for five of the six subjects (with the
exception of subject 3).
Figure 7 shows examples of the changes observed in these
metabolites for subjects 2 and 5. In addition, since the PMI
covered by the study varied for each cadaver from as little as
3 days postmortem to 19 days after death, a general idea
could be obtained of how these metabolites changed
throughout this period. They show an increasing trend in all
cases but subject 4 (which was analyzed to PMI 5), sug-
gesting that these metabolites increase later in the postmor-
tem period (between 7 and 19 days postmortem).
Metabolites of interest were selected based primarily on
the predictable and steady rate of change in their levels with
increasing PMI as well as the confidence in the metabolite
identification. Furthermore, selected metabolites have
shown similar trends between the tested human subjects and
the rat tissue, and reinforced the confidence in the selected
compounds. Metabolites of interest include skatole (3-
methylindole), xanthine, n-acetylneuraminate, 1-methyl-
nicotinamide, choline phosphate, uracil, and a number of
amino acids (Table 3) with tyrosine, threonine, and lysine
being the most promising candidates.
Discussion
An untargeted metabolomics approach allowed the
identification of a number of metabolites that show poten-
tial as PMI biomarkers. Two chromatographic methods
were used: pHILIC and HILIC. The numbers of common
metabolites for both rat and human detected by each
chromatographic method were presented (Fig. 1), illus-
trating the enhanced metabolomic coverage that can be
achieved by combining two chromatographic separations.
A comparable number of metabolites were detected overall
from each tissue, but there is a noticeable difference in the
number of metabolites detected by the HILIC method in the
rat model. This might reflect differences in the kinetics of
postmortem degradation in the much smaller rodent ca-
davers, but more data would be needed to draw any definite
conclusions.
Testing carried out using rat cadavers resulted in a number
of putative markers, mainly proteinogenic amino acids.
Nearly all of the identified amino acids showed a steady rate
of increase during the first 72 h after death. Protein degra-
dation may explain many of the changes observed in this
study. Since there is no more protein synthesis occurring in
dead tissue, the pool of free amino acids does not deplete.
The loss of homeostasis that accompanies death will rapidly
compromise membrane functions that are actively main-
tained, leading to breakdown of cellular and subcellular
structure. The many proteases that are sequestered in living
tissue will gain unregulated access to protein substrates, and
the resulting proteolysis will break down proteins into pep-
tides and, ultimately, amino acids.
Degradation of macromolecules is to be anticipated during
the extending PMI, and we see many changes (both increases
and decreases) in putative markers. Identification of these
Table 3. All Identified Metabolites of Interest
Metabolite name Formula KEGG ID Detected mass RT (min) Metabolite ID code
L-Arginine C6H14N4O2 C00062 174.1116 25.79 HRMS
1
a, Rta
L-Histidine C6H9N3O2 C00135 155.0696 14.59 HRMS
1
a, Rta
L-Leucine C6H13NO2 C00123 131.0946 10.12 HRMS
1
a, Rta
L-Lysine C6H14N2O2 C00047 146.1055 24.39 HRMS
1
a, Rta
L-Methionine C5H11NO2S C00073 149.0511 10.83 HRMS
1
a, Rta
L-Phenylalanine C9H11NO2 C00079 165.079 9.54 HRMS
1
a, Rta
L-Proline C5H9NO2 C00148 115.0633 11.96 HRMS
1
a, Rta
L-Threonine C4H9NO3 C00188 119.0583 13.52 HRMS
1
a, Rta
L-Tryptophan C11H12N2O2 C00078 204.09 10.94 HRMS
1
a, Rta
L-Tyrosine C9H11NO3 C00082 181.0739 12.2 HRMS
1
a, Rta
L-Valine C5H11NO2 C00183 117.079 11.68 HRMS
1
a, Rta
Putrescine C4H12N2 C00134 88.1001 21.97 HRMS
1
a, Rta
Xanthine C5H4N4O2 C00385 152.0334 9.03 HRMS
1
a, Rta
Choline phosphate C5H14NO4P C00588 183.0662 17.52 HRMS
1
a, Rta
Uracil C4H4N2O2 C00106 112.0273 7.985 HRMS
1
a, Rta
L-Asparagine C4H8N2O3 C00152 132.0535 14.48 HRMS
1
a
L-Aspartate C4H7NO4 C00049 133.0375 14.0 HRMS
1
a
L-Cysteine C3H7NO2S C00097 121.0198 13.09 HRMS
1
lib
L-Glutamate C5H9NO4 C00025 147.0532 9.59 HRMS
1
a
L-Serine C3H7NO3 C00065 105.0426 14.97 HRMS
1
a
Cadaverine C5H14N2 C01672 102.1157 22.08 HRMS
1
lib
Indole C8H7N C00463 117.0579 10.59 HRMS
1
lib
Skatole C9H9N C08313 131.0735 10.94 HRMS
1
lib
N-acetylneuraminate C11H19NO9 C00270 309.1061 12.23 HRMS
1
a
1-Methylnicotinamide C7H8N2O C02918 136.0637 24.5 HRMS
1
lib
KEGG ID—number corresponding to a given metabolite in Kyoto Encyclopedia of Genes and Genomes (Kanehisa, 1995), RT—retention
time, Metabolite ID code—suggested coding system for reporting confidence of metabolite identification (Sumner et al., 2014), Rta signifies
retention time matched identifications (high confidence); the remaining are putatively identified.
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molecules was beyond the scope of the current work, but
suggests the possibility that a panel of chemically diverse
markers might be developed to report on PMI.
Well-known bacteria-induced decomposition products,
cadaverine, putrescine, skatole, and indole, also showed
promising patterns of change in the rat. The latter three
compounds increased over time, but cadaverine, surprisingly,
decreased. It is possible that the bacterial action was not
sufficiently advanced to yield significant amounts. In addi-
tion, cadaverine is a metabolite of lysine, which showed
one of the slowest rates of increase among the amino acids
observed.
Five other metabolites were also identified as possible
murine biomarkers: xanthine (a purine base), uracil (a py-
rimidine found in RNA), choline phosphate (the precursor
of choline in glycine, serine, and threonine pathways),
n-acetylneuraminate (otherwise known as sialic acid,
a derivative of the amino sugar neuraminic acid), and 1-
methylnicotinamide (a metabolite of nicotinamide)
(Wishart et al., 2013). All of these compounds increased
with PMI.
These findings were also tested using human tissue at
various stages of decomposition, where subject selection,
cause of death, and ante- and postmortem environment could
not be controlled but where the PMI was significantly longer
than in our rat study (up to19 days after death). Nonetheless,
the data collected using human subjects broadly agreed with
the data obtained from rats. The same compounds were
identified in most of the cadavers and showed similar trends.
The only exceptions were likely microbial decomposition
products (cadaverine, putrescine, and indole), which showed
less apparent changes in human tissue, perhaps because mi-
crobial colonization of the larger human skeletal muscles is
delayed compared with rats. On the contrary, skatole showed
an increasing trend in human tissue.
In addition, certain amino acids (especially histidine and
lysine) showed comparable rates of increase between indi-
vidual rat and human subjects. The quantitative changes in
the levels of amino acids in human tissue were more vari-
able compared with rats, likely because the rat study was
more controlled in subject and environment. In addition, the
human cadavers were sampled at a longer PMI and were
therefore likely in a more advanced stage of decay. The
same muscle was sampled repeatedly from each subject,
allowing exposure to the environment between the times of
sampling.
Amino acids have previously been suggested as possible
markers for PMI estimation. In agreement with this study,
increasing levels of amino acids were reported in various
postmortem specimens, including vitreous humor (Girela
et al., 2008; Patrick and Logan, 1988), cerebrospinal fluid
(Girela et al., 2008; Ka¨rkela¨ and Scheinin, 1992), blood
(Donaldson and Lamont, 2014; Sato et al., 2015), and brain
(Perry et al., 1981). Perry et al. (1981) observed postmortem
increases in levels of various amino acids in rat and human
brain samples up to 48 h after death. These investigators
described a rapid increase in most of the proteinogenic amino
acids within 24–48 h postmortem, with the exception of
glutamate. This is consistent with our observations, where
glutamate was not reliably detected in our rat study, per-
formed over a comparable time period, and showed a modest
increase in human cadavers.
Vass et al. (2002) investigated various compounds in
different postmortem organs and tissues, including muscle
tissue. Similar to our findings in human tissue, this group
found the most commonly known decomposition products
(cadaverine and putrescine) to be unsuitable for time since
death determination due to their variability. The authors de-
scribed various amino acids as good biomarker candidates.
However, according to their findings, muscle tissue can only
be used to determine PMI >300 CDH. This is contrary to our
findings, as we found amino acids to be useful biomarkers at
earlier PMI. To put this into context, in this study subject 2
was sampled between 88 and 131.2 CDH (11–14 days post-
mortem) and subject 3 107.2 and 164.8 CDH (11–15 days
postmortem).
In addition, we found lysine to be one of the most prom-
ising biomarker candidates, while Vass et al. (2002) did not
find lysine to be a consistent indicator of PMI in any of the
tissue types analyzed.
To our knowledge, xanthine, uracil, choline phosphate,
n-acetylneuraminate, and 1-methylnicotinamide have not
previously been suggested as possible PMI markers. Len-
doiro et al. (2012) presented an LC-MS/MS method of PMI
estimation based on the measurement of hypoxanthine levels
in vitreous humor. The method was also validated to quantify
levels of xanthine, however, not as a potential marker. An-
other study by Kova´cs et al. (2005) showed increasing levels
of both xanthine and uracil during the first 24 h postmortem in
rat and human brains. These findings are in agreement with
the data presented in this article. However, PMI determina-
tion was not the objective of their investigation.
Conclusions
In this study, we aimed to test the potential for metabo-
lomics to reveal markers for PMI, and we did not have
sufficient resource to assess the large numbers of subjects
that would be required to generate markers that might be
employed with confidence in forensic investigations. Never-
theless, large clinical metabolomic studies, involving hun-
dreds of subjects, can report on a large range of metabolites
and reveal markers for complex pathologies (Rattray et al.,
2019). Such approaches could readily be applied to post-
mortem samples.
Muscle tissue has rarely been the focus of PMI research;
however, it has veritable potential as a forensic specimen.
Superficial muscle tissue is very easy to collect and less
emotive for the next of kin. In addition, it is more stable
postmortem than other organs or body fluids. As demon-
strated in this study, it can be easily applied in PMI investi-
gations. Various compounds show a steady increase over
time, with threonine, tyrosine, and lysine showing the most
potential as biomarkers.
However, more work is required to validate these results.
The next step would be to apply targeted analysis in a larger
cohort of subjects to evaluate the selected metabolites.
Quantification of the concentrations of these compounds
would allow statistical analysis of the data and possibly the
development of a mathematical model for the estimation of
PMI using muscle tissue. Importantly, instrumentation and
methods for the quantification of amino acids in biological
samples are well developed and are ubiquitous in clinical
biochemistry laboratories.
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Taken together, this study demonstrates how a biomarker
discovery approach can be extended to forensic investiga-
tions using untargeted metabolomics.
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